Heron Therapeutics Inc (NASDAQ:HRTX)

Delayed Data
As of Mar 20
 -0.70 / -2.56%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 12 analysts offering 12-month price forecasts for Heron Therapeutics Inc have a median target of 28.00, with a high estimate of 42.00 and a low estimate of 26.00. The median estimate represents a +5.26% increase from the last price of 26.60.

Analyst Recommendations

The current consensus among 12 polled investment analysts is to Buy stock in Heron Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 41.65%
Growthannually 30.24%


Growthquarterly 7.66%
Growthannually 123.88%
Key to the earnings and sales forecast charts.